Christopher Benton, MD
Dr. Benton is a board-certified hematologist and medical oncologist specializing in acute and chronic leukemias, blood cancers, and non-malignant blood disorders. He earned his medical degree and completed internal medicine residency at Baylor College of Medicine, followed by fellowship in medical oncology and hematology at MD Anderson Cancer Center. His research focuses on molecular genomics and clinical research in blood cancers, with extensive publications and presentations on leukemia and myeloid disorders. He serves as a principal investigator for clinical trials and participates in hematology research leadership.
Areas of Focus: Acute Leukemia, Chronic Leukemia, AML, ALL, CML, MDS, Myeloproliferative Neoplasms, Blood Disorders, Clinical Trials
Latest Content
Luspatercept in Low-Risk MDS
06/24/2026
Luspatercept: Clinical Trial Data and Lessons for Low-Risk MDS
Luspatercept in Low-Risk MDS
06/23/2026
Recent Advancements in Defining, Diagnosing, and Staging MDS
Luspatercept in Low-Risk MDS
06/22/2026